Comparison of the Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and Caucasian Patients With Imatinib-Resistant Chronic Phase Chronic Myeloid Leukemia

ConclusionThese results suggest that mutational analysis is invaluable for choosing an appropriate second-line TKI in Asia.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research